USSTOCK.TODAY
After-Market
Log in Sign up

Vertex Pharmaceuticals Q3 revenue increased, but earnings per share missed expectations

Earnings Whispers +1 · ·by G4L

VRTX Vertex Pharmaceuticals Inc
$547.09 +0.85%
View chart & analysis →
  1. 1Vertex Pharmaceuticals recorded Q3 revenue of $3,441,000,000, an 11.8% increase.
  2. 2Vertex Pharmaceuticals' Q3 Non-GAAP earnings per share missed the consensus by 6.7%.
  3. 3The decline in profitability was not a demand issue but a result of the company's intentional choice regarding costs and capital structure.

So what's the key point?

Vertex Pharmaceuticals' revenue grew to $3,441,000,000, but earnings per share were lower than what experts expected. This was not because of low demand, but because the company decided to spend more on costs.

Source Earnings Whispers +1 · View original ↗

Related 3-line summaries

Vertex Pharmaceuticals Q3 Revenue Up 12% · Annual Guidance Raised The Motley Fool +1 · 6d agoAmgen and Vertex Pharmaceuticals: Economies of Scale and Steady Revenue Growth The Motley Fool +1 · Oct 28SpaceX records $4.4 billion in Q3 net profit including investment gains from The Boring Company The Motley Fool +1 · Oct 24
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news